| The effect of olanzapine on cognitive functions of patients with schizophreni | İbrahim EREN, Çivi İkbal İNANLI | 213–222 |
| Evaluation of compliance to treatment and factors affecting compliance for schizophrenia outpatients | Emin ÖNDER, Oğuz KARAMUSTAFALIOĞLU, Mesut ÇELİN, Nesrin DİLBAZ, Timuçin ORAL | 223–232 |
| The prevalence of obesity and weight gain among the patients with psychotic disorder who use antipsychotic medication, one year follow-up. | Cem CERİT, Suna CANDAN, Mustafa YILDIZ | 233–238 |
| Şizofreni tedavisinin yıllık maliyeti: Bir üniversite hastanesi verilerinden yapılan hesaplama | Cem CERİT, Mustafa YILDIZ | 239–244 |
| Antidepressant-discontinuation induced mania: A case report and review of the literature | A. Ender ALTINTOPRAK, Hakan COŞKUNOL, Özen Önen SERTÖZ | 245–251 |
| Prodrome schizophrenia: Current developments and problems | H. Murat EMÜL, M. Müfit UĞUR | 252–262 |
| Delayed-onset drug-induced movement disorders | Erhan KURT, Oya ÖZTÜRK, Timuçin ORAL | 263–273 |
| Biological and evolutional basis of the human sexuality | Ertuğrul EŞEL | 274–288 |